OBJECTIVE: Missed period pills (MPP) are uterine evacuation medications used for treatment of delayed menses without prior pregnancy confirmation . This study explores potential interest in missed period pills in two US states . STUDY
DESIGN: We enrolled people seeking pregnancy test services at nine health centers in two US states between June 2015 and October 2017 . Participants completed an anonymous questionnaire containing closed- and open-ended questions about background characteristics, reproductive practices, pregnancy feelings and intentions, abortion attitudes, and MPP interest . We used ordered logistic regression to identify factors associated with MPP interest and inductive content analysis to identify recurring qualitative themes related to MPP interest or disinterest .
RESULTS: In all, 678 people completed the survey and 286/678 (42 %) indicated interest in missed period pills . Interest was greatest (129/185 or 70 %) among those who would be unhappy if pregnant . Variables associated with interest in the multivariate analyses were age ≥35, nulliparity, prior abortion and contraceptive use, recent use of emergency contraception, pregnancy feelings and intentions, and abortion attitudes (p <.05). Variables not associated with interest included state of residence, educational attainment, ethnicity, religious affiliation, and frequency of religious attendance . Key reasons for interest were to prevent, avoid or terminate pregnancy; and psychological or emotional benefits, including management of abortion stigma . Reasons for non-interest included concerns about safety or side effects, desire to be pregnant or have a baby, and not wanting to abort or hurt the fetus/baby .
CONCLUSION: If missed period pills were available in the United States, demand might be substantial and wide-ranging across demographic groups .
IMPLICATIONS: Our findings suggest that some people with missed periods do not desire pregnancy confirmation before taking medications that might disrupt a pregnancy . As a result, provision of missed period pills in the United States would expand reproductive service options and could improve the delivery of patient-centered care.